rs55664929
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000552.5(VWF):c.5664+33G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00986 in 1,610,032 control chromosomes in the GnomAD database, including 1,214 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.056 ( 720 hom., cov: 32)
Exomes 𝑓: 0.0051 ( 494 hom. )
Consequence
VWF
NM_000552.5 intron
NM_000552.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.75
Genes affected
VWF (HGNC:12726): (von Willebrand factor) This gene encodes a glycoprotein involved in hemostasis. The encoded preproprotein is proteolytically processed following assembly into large multimeric complexes. These complexes function in the adhesion of platelets to sites of vascular injury and the transport of various proteins in the blood. Mutations in this gene result in von Willebrand disease, an inherited bleeding disorder. An unprocessed pseudogene has been found on chromosome 22. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 12-6012054-C-T is Benign according to our data. Variant chr12-6012054-C-T is described in ClinVar as [Benign]. Clinvar id is 256686.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-6012054-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.185 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0557 AC: 8469AN: 152118Hom.: 721 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
8469
AN:
152118
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00690 AC: 1715AN: 248640 AF XY: 0.00534 show subpopulations
GnomAD2 exomes
AF:
AC:
1715
AN:
248640
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00507 AC: 7391AN: 1457798Hom.: 494 Cov.: 31 AF XY: 0.00439 AC XY: 3187AN XY: 725522 show subpopulations
GnomAD4 exome
AF:
AC:
7391
AN:
1457798
Hom.:
Cov.:
31
AF XY:
AC XY:
3187
AN XY:
725522
Gnomad4 AFR exome
AF:
AC:
5138
AN:
31278
Gnomad4 AMR exome
AF:
AC:
505
AN:
44598
Gnomad4 ASJ exome
AF:
AC:
158
AN:
26086
Gnomad4 EAS exome
AF:
AC:
1
AN:
39694
Gnomad4 SAS exome
AF:
AC:
53
AN:
86228
Gnomad4 FIN exome
AF:
AC:
1
AN:
53420
Gnomad4 NFE exome
AF:
AC:
771
AN:
1110600
Gnomad4 Remaining exome
AF:
AC:
687
AN:
60146
Heterozygous variant carriers
0
247
494
742
989
1236
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0558 AC: 8488AN: 152234Hom.: 720 Cov.: 32 AF XY: 0.0533 AC XY: 3971AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
8488
AN:
152234
Hom.:
Cov.:
32
AF XY:
AC XY:
3971
AN XY:
74452
Gnomad4 AFR
AF:
AC:
0.188603
AN:
0.188603
Gnomad4 AMR
AF:
AC:
0.028239
AN:
0.028239
Gnomad4 ASJ
AF:
AC:
0.00806452
AN:
0.00806452
Gnomad4 EAS
AF:
AC:
0.000192827
AN:
0.000192827
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.00139636
AN:
0.00139636
Gnomad4 OTH
AF:
AC:
0.051561
AN:
0.051561
Heterozygous variant carriers
0
322
644
965
1287
1609
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at